Patients with type 2 diabetes can prolong kidney health by meeting American Diabetes Association (ADA) target levels for hemoglobin A1c (HbA1c), BP, cholesterol, and triglycerides.
The multifactorial intervention proved successful in a study of 1,290 Chinese individuals with type 2 diabetes and normal albumin levels.
During the 4.5-year study, new-onset albuminuria developed in 211 patients (16.4%), researchers reported in Archives of Internal Medicine (2010;170:155-161).
Continue Reading
The achievement of three ADA goals in particular significantly reduced the risk for this occurrence:
HbA1c below 7% decreased the risk of new-onset microalbuminuria by 27.1%.
Systolic pressure below 130 mm Hg decreased risk by 35.5%.
HDL cholesterol levels above 50 mg/dL for women and above 40 mg/dL for men decreased risk by 28.5%.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.